ZKSCAN3 was also shown to interact with the cyclin D2 (CCND2) promoter and activate its expression in multiple myeloma, in which ZKSCAN3 is also highly expressed compared to normal samples (Figure 4) [127]. This evidence concerns the gene ZKSCAN3 and plasma cell myeloma.